TATTON: Osimertinib plus savolitinib for patients with EGFR-mutant, MET-amplified NSCLC after progression on EGFR-TKI

Using T cell engineering plus triple checkpoint blockade to enhance the efficacy of adoptive immunotherapy in ovarian cancer

The hereditary link between African-Americans and people in Africa and its relationship to cancer incidence and outcomes

Combining the SLP vaccine with chemo-immunotherapy in order to increase the HPV-specific T-cell response in cervical cancer

Digitising clinical assessment and using it for evidence-based prediction of outcomes

African Access Initiative: Improving patient outcomes in Africa

Umbralisib as a monotherapy in patients with relapsed/refractory marginal zone lymphoma

Risk factors for prostate cancer in men of African descent

Using regionally delivered autologous mesothelin-targeted CAR T cells in the treatment of malignant pleural disease

Tumour shrinkage with ipilimumab plus nivolumab in patients with neuroendocrine carcinoma

Increased stroke risk in childhood cancer survivors

KEYNOTE 189: Targeting NSCLC patients with brain and liver metastases